Replies to post #43 on Adhera Therapeutics Inc (ATRX)

[DewDiligence]

>With an ANDA, the clinical studies can only test for bioequivalence, so other studies, including immunogenicity studies, cannot be done<

I don’t agree with this. Studies other than for bioequivalence are generally not done in an ANDA, but that doesn’t mean that they can’t be done.

[endofwar]

Thanks for that posting. In it, there is a quote about missing an opportunity on LEAPS. I thought the longest duration options currently available expire in December 06. Are there LEAPS? regards endo